ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 922

Risk of Fracture Among Treated and Untreated Men with Osteoporosis

Karen Tomic1, Joanne Lafleur2, Liisa Palmer1, David M. Smith1, Carly J. Paoli3, Irene Agodoa3 and Nicole Yurgin3, 1Truven Health Analytics, Washington, DC, 2University of Utah College of Pharmacy, Salt Lake City, UT, 3Amgen Inc, Thousand Oaks, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: fractures and osteoporosis

  • Tweet
  • Email
  • Print
Session Information

Session Title: Epidemiology and Health Services Research: Epidemiology and Outcomes of Rheumatic Disease II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Osteoporosis (OP) affects an estimated 2 million men in the United States. The relationship between treatment and fracture outcomes has been reported from clinical trial populations, but little is known about the impact of treatment on fracture risk among men with OP in the real-world setting.

Methods: The MarketScan® Medicare Supplemental and Coordination of Benefits Database was used to identify treated (received an OP medication) and untreated (had an OP diagnosis or fragility fracture but no OP medication) men with OP between 1/1/04 and 4/30/10 and at least 12 months pre-period and 3 months post-period follow-up in the database.  Patients were matched on pre-period fracture and age (± 2 years).  Follow-up time was variable and ended with fracture, inpatient death, end of health plan eligibility, or on 4/30/10, whichever came first.  Fracture incidence rates and time to fracture were reported.  A Cox proportional hazards model was used to assess whether treated men had a lower risk of fracture compared to untreated men after controlling for demographic and clinical characteristics.

Results: Of the 3,072,696 men ≥65 years in the database, a total of 31,696 men met the inclusion and match criteria (15,848 in each cohort).  In both cohorts, the mean age was 78 years and 55% had a pre-period fracture.  1,990 treated men had a follow-up fracture [incidence = 5.98/100 person-years (p-y)] over 33,274 p-y of follow-up, compared to 2,231 untreated men with a follow-up fracture (incidence = 8.03/100 p-y) over 27,785 p-y.  Treated men also had longer mean time to fracture (588 days, SD 426) than untreated men (401 days, SD 372, p<0.001).  The adjusted risk of fracture was lower among treated men compared to untreated men (adjusted hazards ratio = 0.83, 95% CI: 0.78 to 0.89).  Other pre-period factors associated with an increased risk of fracture were urban residence, no bone mineral density test, use of benzodiazepines, and a higher number of comorbidities and concomitant medications.

Conclusion:

The fracture incidence rate was lower and time to fracture was longer for men with OP who received treatment than for those without treatment. After controlling for prior fracture and other risk factors, treated men had a lower adjusted risk of fracture.  To better characterize the benefit of OP treatment, more research is needed into the role of medication adherence and risk of fracture among men with OP.


Disclosure:

K. Tomic,

Amgen,

5;

J. Lafleur,

Agency for Healthcare Research and Quality, Amgen, Anolinx, Genentech, United States Centers for Disease Control, United States Department of Defense,

5,

Amgen,

5;

L. Palmer,

Amgen,

5;

D. M. Smith,

Amgen,

5;

C. J. Paoli,

Amgen,

1,

Amgen,

3;

I. Agodoa,

Amgen,

1,

Amgen,

3;

N. Yurgin,

Amgen,

1,

Amgen,

3.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-of-fracture-among-treated-and-untreated-men-with-osteoporosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences